Identification of novel metastasis suppressor signaling pathways for breast cancer

Cell Cycle

Volumn 11, Issue 13, 2012, Pages 2452-2457

  Minn, Andy J ^a   Bevilacqua, Elena ^b   Yun, Jieun ^c   Rosner, Marsha Rich ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Breast cancer; Gene set analysis; Gene set enrichment analysis; Gene signature; Invasion; Metastasis; Raf kinase inhibitory protein; Random forests; Signaling pathway

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; G PROTEIN COUPLED RECEPTOR; HIGH MOBILITY GROUP A2 PROTEIN; INTERSTITIAL COLLAGENASE; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; UNTRANSLATED RNA;

BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER MODEL; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CHI SQUARE TEST; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENE REGULATORY NETWORK; GENE TARGETING; GENETIC CORRELATION; GENETIC HETEROGENEITY; GENOME; GENOMIC INSTABILITY; HUMAN; LETHALITY; METASTASIS; NONHUMAN; PHENOTYPE; REDUNDANCY ANALYSIS; REVIEW; SIGNAL NOISE RATIO; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; TUMOR MICROENVIRONMENT; VALIDATION PROCESS;

EID: 84863806414     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.20624     Document Type: Review

References (37)

1. Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, et al. Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci USA 2010; 107:18545-50; PMID:20876136; http://dx.doi.org/10.1073/pnas. 1010978107.
2. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, Angenendt P, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008; 321:1801-6; PMID:18772397; http://dx.doi.org/10.1126/ science.1164368.
3. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007; 318:1108-13; PMID:17932254; http://dx.doi.org/10.1126/science.1145720.
4. Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003; 3:537-49; PMID:12842083; http://dx.doi.org/10.1016/S1535-6108(03) 00132-6.
5. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, et al. Genes that mediate breast cancer metastasis to lung. Nature 2005; 436:518-24; PMID:16049480;http://dx.doi.org/10.1038/nature03799.
6. Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C, et al. Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 2007; 446:765-70; PMID:17429393; http://dx.doi.org/10.1038/nature05760.
7. Gupta GP, Perk J, Acharyya S, de Candia P, Mittal V, Todorova-Manova K, et al. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci USA 2007; 104:19506-11; PMID:18048329; http://dx.doi.org/10. 1073/pnas.0709185104.
8. Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF, Morris PG, et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med 2011; 17:867-74; PMID:21706029; http://dx.doi.org/10.1038/nm.2379.
9. Chen Q, Zhang XH, Massagué J. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell 2011; 20:538-49; PMID:22014578; http://dx.doi.org/10.1016/j.ccr. 2011.08.025.
10. Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis. Nature 2008; 452:187-93; PMID:18337816; http://dx.doi.org/10.1038/nature06781.
11. Tavazoie SF, Alarcón C, Oskarsson T, Padua D, Wang Q, Bos PD, et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008; 451:147-52; PMID:18185580; http://dx.doi.org/10.1038/nature06487.
12. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010; 464:1071-6; PMID:20393566;http://dx.doi.org/10.1038/nature08975.
13. Ma L, Weinberg RA. Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet 2008; 24:448-56; PMID:18674843; http://dx.doi.org/10.1016/j.tig.2008.06.004.
14. Nguyen DX, Chiang AC, Zhang XH, Kim JY, Kris MG, Ladanyi M, et al. WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 2009; 138:51-62; PMID:19576624;http://dx.doi.org/10.1016/j. cell.2009.04.030.
15. Valastyan S, Reinhardt F, Benaich N, Calogrias D, Szász AM, Wang ZC, et al. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis. Cell 2009; 137:1032-46; PMID:19524507; http://dx.doi.org/10.1016/j. cell.2009.03.047.
16. Zhang XH, Wang Q, Gerald W, Hudis CA, Norton L, Smid M, et al. Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell 2009; 16:67-78; PMID:19573813; http://dx.doi.org/10.1016/j.ccr.2009.05.017.
17. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102:15545-50; PMID:16199517; http://dx.doi.org/10.1073/pnas.0506580102.
18. Huynh-Thu VA, Irrthum A, Wehenkel L, Geurts P. Inferring regulatory networks from expression data using tree-based methods. PLoS ONE 2010; 5:12776;PMID:20927193; http://dx.doi.org/10.1371/journal.pone.0012776.
19. Ideker T, Dutkowski J, Hood L. Boosting signal-tonoise in complex biology: prior knowledge is power. Cell 2011; 144:860-3; PMID:21414478; http://dx.doi.org/10.1016/j.cell.2011.03.007.
20. Efron B, Tibshirani R. On testing the significance of sets of genes. Annals of Applied Statistics 2007; 1:107-29; http://dx.doi.org/10.1214/07- AOAS101.
21. Breiman L. Random Forests. Mach Learn 2001; 45:5-32; http://dx.doi.org/ 10.1023/A:1010933404324.
22. Dangi-Garimella S, Yun J, Eves EM, Newman M, Erkeland SJ, Hammond SM, et al. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J 2009; 28:347-58; PMID:19153603; http://dx.doi.org/10.1038/emboj.2008.294.
23. Granovsky AE, Rosner MR. Raf kinase inhibitory protein: a signal transduction modulator and metastasis suppressor. Cell Res 2008; 18:452-7; PMID:18379591;http://dx.doi.org/10.1038/cr.2008.43.
24. Corbit KC, Trakul N, Eves EM, Diaz B, Marshall M, Rosner MR. Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J Biol Chem 2003; 278:13061-8; PMID:12551925; http://dx.doi.org/10.1074/jbc.M210015200.
25. Trakul N, Menard RE, Schade GR, Qian Z, Rosner MR. Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation. J Biol Chem 2005;280:24931-40; PMID:15886202; http://dx.doi.org/10.1074/jbc.M413929200.
26. Lorenz K, Lohse MJ, Quitterer U. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 2003; 426:574-9; PMID:14654844; http://dx.doi.org/10.1038/nature02158.
27. Yeung KC, Rose DW, Dhillon AS, Yaros D, Gustafsson M, Chatterjee D, et al. Raf kinase inhibitor protein interacts with NFkappaB-inducing kinase and TAK1 and inhibits NFkappaB activation. Mol Cell Biol 2001; 21:7207-17; PMID:11585904; http://dx.doi.org/10.1128/MCB.21.21.7207-17.2001.
28. Eves EM, Shapiro P, Naik K, Klein UR, Trakul N, Rosner MR. Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint. Mol Cell 2006; 23:561-74; PMID:16916643; http://dx.doi.org/10.1016/j.molcel.2006.07. 015.
29. Akaishi J, Onda M, Asaka S, Okamoto J, Miyamoto S, Nagahama M, et al. Growth-suppressive function of phosphatidylethanolamine-binding protein in anaplastic thyroid cancer. Anticancer Res 2006; 26:4437-42;PMID:17201166.
30. Al-Mulla F, Hagan S, Behbehani AI, Bitar MS, George SS, Going JJ, et al. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. J Clin Oncol 2006; 24:5672-9; PMID:17179102;http://dx.doi.org/ 10.1200/JCO.2006.07.5499.
31. Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R, Rhodes D, et al. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 2006; 66:248-56; PMID:16175585;http://dx.doi.org/ 10.1002/pros.20319.
32. Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst 2003; 95:878-89; PMID:12813171;http://dx.doi.org/ 10.1093/jnci/95.12.878.
33. Hagan S, Al-Mulla F, Mallon E, Oien K, Ferrier R, Gusterson B, et al. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 2005; 11:7392-7;PMID:16243812; http://dx.doi.org/10.1158/1078-0432.CCR-05-0283.
34. Schuierer MM, Bataille F, Hagan S, Kolch W, Bosserhoff AK. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Res 2004; 64:5186-92;PMID:15289323; http://dx.doi.org/10.1158/0008-5472. CAN-03-3861.
35. Yun J, Frankenberger CA, Kuo WL, Boelens MC, Eves EM, Cheng N, et al. Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO J 2011; 30:4500-14; PMID:21873975; http://dx.doi.org/10.1038/emboj. 2011.312.
36. Park SM, Shell S, Radjabi AR, Schickel R, Feig C, Boyerinas B, et al. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 2007; 6:2585-90;PMID:17957144; http://dx.doi.org/10.4161/cc.6.21.4845.
37. Bevilacqua E, Frankenberger CA, Rosner MR. RKIP Suppresses Breast Cancer Metastasis to the Bone by Regulating Stroma-Associated Genes. Int J Breast Cancer 2012; 2012:124704; PMID:22482058; http://dx.doi.org/10.1155/2012/124704.